Tropicamide: uses, dosing, side effects & brands

Tropicamide is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.

By the pharmaranks editorial teamReviewed against the FDA (openFDA label, NDC Directory & Enforcement) sourcesUpdated Jul 24, 2026How we research

Key facts

Available as: Drops
Sold as: Mydriacyl
Prescription?: Prescription only
Generic available?: Not in our catalog
What the pharmacy pays: about $0.52 per ml — not your price

Every tropicamide product we track (1)

Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.

Only one: Mydriacyl.

Combination products containing tropicamide

A combination is a different drug — different dosing, different warnings. It is listed here so you can find it, not so you can substitute it.

Tropicamide recalls

From the FDA Enforcement database. A recall covers specific lots — not the drug as a whole.

Tropicamide and breastfeeding

From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.

No information is available on the use of tropicamide during breastfeeding. Anticholinergic drugs might interfere with breastfeeding. A single dose of ophthalmic tropicamide is not likely to interfere with breastfeeding; however, during long-term use, observe the infant for signs of decreased lactation (e.g., insatiety, poor weight gain). To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.

Full LactMed record for tropicamide: levels in milk, effects in breastfed infants, and the drugs it would consider instead

National Institute of Child Health and Human Development, record revised April 19, 2021. LactMed states its information is not a substitute for professional judgement.

What people report to the FDA about tropicamide

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,697 reports naming tropicamide, and the FDA flagged 82% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

vision blurred132 reports
eye pain104 reports
headache89 reports
toxic anterior segment syndrome87 reports
visual acuity reduced86 reports
endophthalmitis72 reports
dizziness70 reports
visual impairment66 reports

Read these as a signal, not a rate. A report does not mean tropicamide caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.

Source: openFDA drug/event (FAERS), retrieved July 26, 2026.

Related calculators

How long it stays in your system →

Frequently asked questions

Can you take tropicamide with other medicines?

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run tropicamide against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

What forms does tropicamide come in?

Across the brands we track, tropicamide is currently marketed as drops, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Is there a generic tropicamide?

We do not currently list a generic-labelled tropicamide product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

Has tropicamide been recalled?

The FDA's Enforcement database lists 3 recall records whose product description mentions tropicamide. The most recent: Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophth… (Nov 20, 2025). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

Cite this page

APA: pharmaranks. (2026, July 24). Tropicamide: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/tropicamide
MLA: “Tropicamide: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/tropicamide.

We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.

Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.

Read the full FDA label for tropicamide on DailyMed (NIH) ↗.